Netflix's Q1 results receive mixed reviews from analysts, causing stock fluctuations.
UBS upgraded Netflix to Buy from Neutral and raised its price target to $390.00 from $350.00 following the company’s reported worse-than-expected Q1 revenue results and guidance yesterday. Meanwhile, UBS also upgraded ExxonMobil to Buy from Neutral and raised its price target to $144.00 from $125.00. JMP Securities upgraded LegalZoom.com to Market Outperform from Market Perform with a price target of $14.00. Additionally, Mizuho Securities upgraded Immuneering to Buy from Neutral and Morgan Stanley upgraded the company to Equalweight from Underweight. Baird upgraded Global Payments to Outperform from Neutral and raised its price target to $156.00 from $130.00.